FORMULATION AND EVALUATION OF FLOATING DRUG DELIVERY SYSTEM OF REPAGLINIDE
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i6.47271Keywords:
Repaglinide, Moringa oliefera gum, HPMC K100M, Sodium alginate, Calciumcarbonate, Sodium citrateAbstract
Objective: The present study’s is to develop floating drug delivery system of repaglinide.
Methods: Moringa gum, Repaglinide, HPMC K100M, Sodium alginate, Calcium Carbonate, Sodium Citrate. The obtained formulation was evaluated for drug content, pH, in vitro gelling capacity, in vitro buoyancy studies, and in vitro dissolution studies.
Results and Discussion: All the total F1-F12 formulations showed pH ranging from 5.1 to 7.9, floating lag time of F1-F12 ranging from 5 s to 12 s with total floating time greater than 12 h, viscosity of F1-F12 ranging from 619 to 3856 cp, drug content of F1-F12 ranging from 31.2% to 93.1%, and percent drug release of F1-F12 ranging from 78.9% to 93.9%. Dissolution studies showed that F12 formulation-containing drug (30 mg) and polymer (4000 mg) showed 93.9% drug release in 12 h which is said to be optimized. Thus, the best formulation (F12) was subjected for a 3-month period of stability studies found to be stable and reported no significant change.
Conclusion: The study’s goal is to develop and evaluate floating in situ gel forming solution of repaglinide with moringa gum as rate retardant polymer.
Downloads
References
Ubhe TS, Gedam P. A brief overview on Tablet and it’s types. J Adv Pharmacol 2020;1:21-30.
Patil P, Rashmi P. Overview of formulation, manufacture and application of tablets. Int J Curr Pharm Res 2020;12:5-10.
Nagashree K. Solid dosage forms: Tablets. Res Rev J Pharm Anal 2015;5:2-13.
Shahwal VK, Upadhyay A. Gastro-retentive floating drug delivery systems. Int J Biol Med Res 2011;2:381-90. doi: 10.7439/ijbr.v2i6.118
Fatema K, Shahi SR, Shaikh T, Zaheer Z. Gastro retentive drug delivery system: An overview. Asian Pac J Health Sci 2016;3:131-44.
Manmohan M, Shukla TP, Mathur A, Upadhyay N, Sharma S. A review on gastro retentive drug delivery system: An emerging approach to improve the gastric residence time of solid dosage forms. Int J Pharm Sci Rev Res 2011;8:176-82.
Hwang SJ, Park H, Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug Carrier Syst 1998;15:243-84. PMID 9699081
Whitehead L, Fell JT, Collett JH. Development of a gastro retentive dosage form. Eur J Pharm Sci 1996;4(Suppl):182-96.
Nayak AK, Maji R, Das B. Gastro retentive drug delivery systems: A review. Asian J Pharm Clin Res 2010;3:2-10.
Soni RP, Patel AV, Patel RB, Patel MR, Patel KR, Patel NM. Gastro retentive drug delivery systems: A review. Int J Pharm World Res 2001;2:1-24.
Robinson JR. Sustained and Controlled Release Drug Delivery System. 2nd ed. New York City: Marcel Dekker; 2016. p. 138-71.
Martha S. Development and in-vitro evaluation of perindopril floating tablets. World J Pharm Res 2015;4:1010-21.
Reddy GJ, et al. Developed and Optimized a Controlled Release DDS of Nizatidine. Scholars Research Library; 2011. p. 454-65.
Kumar S, Pandey M, Saraf SA. Novel sustained release gastro retentive floating matrix tablets of acyclovir: Formulation and in vitro evaluation. J Pharm Res 2009;2:717-22.
Havaldar VD. Formulation and evaluation of floating matrix tablets of atenolol. Asian Pharm 2010;6:4-16.
Chithaluru K. formulation and evaluation of floating matrix tablets of pioglitazone hydrochloride delivery. Arch Global Professionals 2012;3:12-20.
Sharma P, Verma AM, Chaudhary R, Joshi V. Formulate and evaluate floating tablet of ofloxacin using HPMC. Asian J Pharm Sci Technol 2016;6:115-9.
Dalvadi HP. Design and evaluation of gastro retentive tablets of atenolol using HPMC polymer. Eur J Parenter Pharm Sci 2011;16:87-92.
Patel VM, Prajapati BG, Patel AK. Controlled release gastro retentive dosage form of Verapamil hydrochloride. Int J Pharm Tech Res 2009;1:215-21.
Khan F, et al. Prepared and Evaluated Gastro Retentive Floating Tablets of Theophylline Loaded Gastro Retentive Floating Tablets of Methocel. 2009;K4M:27.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Asma Begum
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
